SS Innovations International (SSII) Liabilities and Shareholders Equity (2016 - 2026)
SS Innovations International's (SSII) quarterly Liabilities and Shareholders Equity came in at $90.5 million in Q1 2026, up 42.69% year-on-year from $63.5 million in Q1 2025, and up 21.99% quarter-over-quarter from $74.2 million in Q4 2025.
SS Innovations International (SSII) Liabilities and Shareholders Equity (2016 - 2026) Analysis & Trends
SS Innovations International has disclosed Liabilities and Shareholders Equity across 11 years of filings, most recently posting $90.5 million for Q1 2026.
- Liabilities and Shareholders Equity for Q1 2026 came in at $90.5 million, up 42.69% year-over-year; the trailing twelve-month figure through Mar 2026 was $304.3 million (up 68.57% YoY), and the FY2025 annual result was $74.2 million, up 75.12% from the prior year.
- Liabilities and Shareholders Equity came in at $90.5 million for Q1 2026 at SS Innovations International, up from $74.2 million in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $90.5 million in Q1 2026 to a low of $279336.0 in Q2 2022.
- The 5-year median for Liabilities and Shareholders Equity is $35.2 million (2024), against an average of $35.7 million.
- Across the five-year window, Liabilities and Shareholders Equity tumbled 36.52% in 2022 and jumped 4349.77% in 2023, its largest moves.
- SS Innovations International's Liabilities and Shareholders Equity stood at $7.0 million in 2022, then surged by 351.48% to $31.5 million in 2023, then jumped by 34.49% to $42.4 million in 2024, then soared by 75.12% to $74.2 million in 2025, then grew by 21.99% to $90.5 million in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $90.5 million (Q1 2026), $74.2 million (Q4 2025), and $69.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 91.49 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 31.92 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 6.63 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 10.74 Bn |
| 10 | SS Innovations International | 689.95 Mn | 666.34 Mn | 5.33 Mn | 90.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 90.55 Mn |
| Dec 31, 2025 | 74.23 Mn |
| Sep 30, 2025 | 69.58 Mn |
| Jun 30, 2025 | 69.98 Mn |
| Mar 31, 2025 | 63.46 Mn |
| Dec 31, 2024 | 42.39 Mn |
| Sep 30, 2024 | 39.02 Mn |
| Jun 30, 2024 | 35.67 Mn |
| Mar 31, 2024 | 35.20 Mn |
| Dec 31, 2023 | 31.52 Mn |
| Sep 30, 2023 | 28.16 Mn |
| Jun 30, 2023 | 12.43 Mn |
| Mar 31, 2023 | 5.47 Mn |
| Dec 31, 2022 | 6.98 Mn |
| Sep 30, 2022 | 1.65 Mn |
| Jun 30, 2022 | 279,336.00 |
| Mar 31, 2022 | 367,396.00 |
| Dec 31, 2021 | 428,607.00 |
| Sep 30, 2021 | 334,401.00 |
| Jun 30, 2021 | 440,038.00 |